RB Capital Management’s Labcorp LH Stock Holding History

RB Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,344	Closed	-$236K	–	174
2022 Q3	$236K	Sell	1,344 -472	-26%	-$96.6K	0.09%	155
2022 Q2	$366K	Sell	1,816 -158	-8%	-$33.7K	0.14%	120
2022 Q1	$447K	Sell	1,974 -18	-0.9%	-$4.23K	0.14%	117
2021 Q4	$538K	Buy	1,992 +180	+10%	+$44.6K	0.17%	100
2021 Q3	$438K	Buy	+1,812	New	+$457K	0.16%	112

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RB Capital Management's LH Position: Q4 2022 in Review

RB Capital Management sold out of Labcorp (LH) in Q4 2022, closing a stake of 1,344 shares — an estimated $236K sold.

RB Capital Management first reported a position in LH in Q3 2021 and held it in 5 quarters. The position peaked at $538K in Q4 2021. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

RB Capital Management reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
RB Capital Management sold 1,344 Labcorp shares in Q4 2022, an estimated $236K.
RB Capital Management first reported a position in Labcorp in Q3 2021 and held it in 5 quarters.
RB Capital Management's Labcorp position peaked at $538K in Q4 2021.
970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on RB Capital Management's 13F filing for Q4 2022, filed 11 Jan 2023.